DR. LEONARD MARK DZUBOW MD
Prescription History 1790778199
Dermatology - MOHS-Micrographic Surgery in Media, PA


Quality Rating: 85.94 out of 100 score

NPI Status: Active since August 31, 2005

Contact Information

101 CHESLEY DR
MEDIA, PA
ZIP 19063
Phone: (610) 566-7846
Fax: (610) 891-6735

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. LEONARD MARK DZUBOW MD, an active MOHS-Micrographic Surgery specialist practicing in Media, PA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 999 documented patient claims. Among these therapy options, the most frequently utilized medication is Mupirocin, which accounts for 787 claims alone.

Medication Index


Cephalexin

Generic Formulation: CephalexinSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 91
PA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.8
Peer Average Days Supply272
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.6% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $88.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.41

State Avg Cost Per Claim

$8.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 120
30-Day Fills 120.0
Days Supply 854
PA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills32.1
Peer Average Days Supply494
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 328.6% higher than the standard regional baseline profile for PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,151.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.59

State Avg Cost Per Claim

$26.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Gentamicin Sulfate

Generic Formulation: Gentamicin SulfateSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 58
30-Day Fills 58.0
Days Supply 623
PA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.6
Peer Average Days Supply425
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 141.7% higher than the standard regional baseline profile for PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,524.23 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.28

State Avg Cost Per Claim

$42.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Therapeutic Applications

This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye and the skin around the eyes (such as eyelids). It is also used to prevent infection after eye injury or surgery. It belongs to a class of drugs known as aminoglycoside antibiotics. Gentamicin works by killing the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. This drug should not be used in newborns due to an increased risk of serious side effects.

Mupirocin

Generic Formulation: MupirocinSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 787
30-Day Fills 787.0
Days Supply 9,010
PA State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills32.7
Peer Average Days Supply487
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 2,359.4% higher than the standard regional baseline profile for PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,573.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.35

State Avg Cost Per Claim

$9.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 52
PA State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills52.4
Peer Average Days Supply1,173
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.7% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $40.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.86

State Avg Cost Per Claim

$22.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. LEONARD MARK DZUBOW MD provides transparency into local medical care patterns within Media, PA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **MOHS-Micrographic Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.